California State Teachers Retirement System Cyma Bay Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.63 - $24.47 $72,382 - $140,237	-5,731 Reduced 6.06%	88,882 $2.1 Million
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $24,022 - $38,975	-2,212 Reduced 2.28%	94,613 $1.41 Million
Q2 2023 Aug 21, 2023	BUY	$7.47 - $10.95 $167,581 - $245,652	22,434 Added 30.16%	96,825 $1.06 Million
Q1 2023 May 09, 2023	BUY	$5.88 - $9.59 $437,419 - $713,409	74,391 New	74,391 $648,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $61,233 - $120,687	-35,601 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $6,947 - $9,129	-2,508 Reduced 6.58%	35,601 $111,000
Q4 2021 Feb 15, 2022	BUY	$3.23 - $4.6 $2,609 - $3,716	808 Added 2.17%	38,109 $129,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $202,675 - $258,163	-58,408 Reduced 61.03%	37,301 $136,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $34,439 - $43,005	-8,741 Reduced 8.37%	95,709 $417,000
Q1 2021 May 18, 2021	SELL	$4.23 - $6.55 $2,000 - $3,098	-473 Reduced 0.45%	104,450 $474,000
Q2 2020 Aug 17, 2020	BUY	$1.41 - $4.25 $7,942 - $23,940	5,633 Added 5.67%	104,923 $366,000
Q1 2020 May 13, 2020	SELL	$1.25 - $2.02 $14,596 - $23,587	-11,677 Reduced 10.52%	99,290 $147,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $6,532 - $29,128	4,912 Added 4.63%	110,967 $217,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $89,558 - $202,208	14,803 Added 16.22%	106,055 $759,000
Q1 2019 May 09, 2019	BUY	$8.16 - $13.42 $1,672 - $2,751	205 Added 0.23%	91,252 $1.21 Million
Q4 2018 Feb 13, 2019	BUY	$6.54 - $11.74 $5,696 - $10,225	871 Added 0.97%	91,047 $717,000
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $54 - $72	-5 Reduced 0.01%	90,176 $999,000
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $961,329 - $1.3 Million	90,181 New	90,181 $1.21 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account